Washington, DC, Sept. 03, 2024 (Korea Bizwire) – The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive Officer, as of September 2024. Mr. Holden succeeds Founder and ten-year CEO Donna R. Cryer, JD, as the chief executive of the [...]
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (Korea Bizwire) – Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to [...]
INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category. As life [...]
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 million in new capital [...]
The GVN MPOX Action Committee is poised to mobilize resources and catalyze efforts in the urgent global call to action TAMPA, Fla., Sept. 02, 2024 (Korea Bizwire) – A correction has been issued for the release disseminated on August 16th. Sten Vermund’s full title was corrected to Sten Vermund, MD, PhD, GVN President and Professor [...]
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt disease SAN DIEGO, Sept. 01, 2024 (Korea Bizwire) – Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel [...]
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 31, 2024 (Korea Bizwire) – A correction has been issued for the release disseminated on August 29th. Sten Vermund’s full title was corrected to Sten Vermund, MD, PhD, GVN President and Professor of Yale University, USA. The complete [...]
SHANGHAI, Aug. 30, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2024, the total revenue of Junshi [...]
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 29, 2024 (Korea Bizwire) – To mitigate the mpox outbreak, the Global Virus Network (GVN) is leading a panel of experts to develop guidelines and streamline testing standards, including strengthening infrastructure to sequencing and early detection. On August 22, [...]
BASEL, Switzerland, Aug. 29, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully concluded its participation in the Association for Medical Education in Europe (AMEE) 2024 Conference, which commenced last Monday in Basel, Switzerland. The three-day event provided a platform for KFSHRC to showcase its expertise in employing the latest technologies [...]